Format

Send to

Choose Destination
Cell Rep. 2013 Jun 27;3(6):2008-20. doi: 10.1016/j.celrep.2013.05.021. Epub 2013 Jun 13.

A mechanism for the upregulation of EGF receptor levels in glioblastomas.

Author information

1
Department of Molecular Medicine, Cornell University, Ithaca, NY 14853, USA.

Abstract

Tissue transglutaminase (tTG) is a GTP-binding protein/acyltransferase whose expression is upregulated in glioblastoma and associated with decreased patient survival. Here, we delineate a unique mechanism by which tTG contributes to the development of gliomas by using two glioblastoma cell lines, U87 and LN229, whose growth and survival are dependent on tTG. We show that tTG significantly enhances the signaling activity and lifespan of EGF receptors (EGFRs) in these brain cancer cells. Moreover, overexpressing tTG in T98G glioblastoma cells that normally express low levels of tTG caused a marked upregulation of EGFR expression and transforming activity. Furthermore, we show that tTG accentuates EGFR signaling by blocking c-Cbl-catalyzed EGFR ubiquitylation through the ability of tTG to bind GTP and adopt a specific conformation that enables it to interact with c-Cbl. These findings demonstrate that tTG contributes to gliomagenesis by interfering with EGFR downregulation and, thereby, promoting transformation.

PMID:
23770238
PMCID:
PMC3742030
DOI:
10.1016/j.celrep.2013.05.021
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center